
6.80 Delayed Data As of May 27 | ![]() Today’s Change | 4.63 Today|||52-Week Range 30.37 | -33.33% Year-to-Date |
INmune Bio (INMB) Down on Clinical Hold for Alzheimer's Study May 25 / Zacks.com - Paid Partner Content | Biotech Stock Roundup: ETTX Up on Acquisition Deal, REGN Offers Updates May 25 / Zacks.com - Paid Partner Content |
Previous close | 6.33 |
Today’s open | 6.47 |
Day’s range | 6.47 - 6.95 |
Volume | 6,287 |
Average volume (3 months) | 154,082 |
Market cap | $132.1M |
Earnings growth (last year) | -86.38% |
Earnings growth (this year) | -5.91% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +1,558.12% |
P/E ratio | NM |
Price/Sales | 909.01 |
Price/Book | 1.64 |
Today’s change | Today’s % change | |
---|---|---|
CRMDCorMedix Inc | -0.08 | -2.52% |
URGNUrogen Pharma Ltd | +0.27 | +5.22% |
TCRTAlaunos Therapeutics... | +0.05 | +10.73% |
SELBSelecta Biosciences ... | +0.07 | +9.96% |
Next reporting date | August 15, 2022 |
EPS forecast (this quarter) | -$0.49 |
Annual revenue (last year) | $181.0K |
Annual profit (last year) | -$30.3M |
Net profit margin | -16,762.43% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boca Raton, Florida |